MS&Fatigue

Was ist Fatigue?

Referenzen

  1. Amato MP, Portaccio E. Management options in multiple sclerosis-associated fatigue. Expert Opinion on Pharmacotherapy 2012; 13: 207 – 216.
  2. Wood B, van der Mei I, Ponsonby AL, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler. 2013 Feb; 19(2): 217 – 24. doi: 10.1177/1352458512450351. Epub 2012 Jun 22.
  3. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9 – 14.
  4. Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol 2001; 248: 174 – 179.
  5. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435 – 437.
  6. Mills RJ, Young CA. The relationship between fatigue and other clinical features of multiple sclerosis.Mult Scler 2011; 17: 604 – 612.
  7. Uhthoff W. Untersuchungen über die bei der multiplen Herdsklerose vorkommenden Augenstörungen. Arch Psychiat Nervenkr 1890; 21: 303 – 410.
  8. Whitaker J, Mitchell G. Clinical features of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple Sclerosis Clinical and Pathogenetic Basis. London: Chapman & Hall Medical, 1997: 3 – 19.
  9. Kobelt G, Thompson A, Berg J, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler 2017; 23: 1123 – 1136.
  10. Hanken K, Eling P, Hildebrandt H. The representation of inflammatory signals in the brain – a model for subjective fatigue in multiple sclerosis. Frontiers in Neurology 2014; 5: 264.
  11. Hanken K, Sander C, Schlake HP, Kastrup A, Eling P, Hildebrandt H. Fatigue in Multiple Sclerosis is related to relapses, autonomic dysfunctions and introversion: A quasi-experimental study. Multiple Sclerosis and Related Disorders 2019; 36: 101401.
  12. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America, 1998.
  13. Bakshi R, Shaikh ZA, Miletich R, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000; 6: 181 – 185.
  14. Krupp LB, Coyle PK, Doscher C, et al. Fatigue therapy in multiple sclerosis: results of a double blind, randomised parallel trial of amantadine, pemoline and placebo. Neurology 1995; 45: 1956 – 1961.
  15. Pellicano C, Gallo A, Li X, et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch Neurol 2010; 67: 447 – 453.
  16. Sepulcre J, Masdeu JC, Goñi J, et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler 2009; 15: 337 – 344.
  17. Yaldizli Ö, Glassl S, Sturm D, et al. Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J Neurol 2011; 258: 2199 – 2205.
  18. Roelcke U, Kappos L, Lechner-Scott J, et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997; 48: 1566 – 1571.
  19. Filippi M, Rocca MA, Colombo B, et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. NeuroImage 2002; 15: 559 – 567.
  20. Jaeger S, Paul F, Scheel M, et al. Multiple sclerosis-related fatigue: Altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex. Multiple Sclerosis Journal 2018; 25: 554 – 564.
  21. Caminero A, Bartolomé M. Sleep disturbances in multiple sclerosis. J Neurol Sci 2011; 309: 86 – 91.
  22. Dias RA, Hardin KA, Rose H, Agius MA, Apperson ML, Brass SD. Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study. Sleep and Breathing 2012; 16: 1255 – 1265.
  23. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245: 41 – 46.
  24. Patti F, Amato MP, Trojano M, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15: 779 – 788.
  25. Flachenecker P, Meissner H. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment. Mult Scler 2008; 14: 274 – 277.
  26. Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol 1996; 53: 185 – 188.
  27. Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579 – 1585.
  28. Busch M, Maske U, Ryl L, Schlack R, Hapke U. Prävalenz von depressiver Symptomatik und diagnostizierter Depression bei Erwachsenen in Deutschland. Bundesgesundheitsblatt 2013; 56: 733 – 739.
  29. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 1990; 47: 98 – 104.
  30. Minden SL, Schiffer RB. Depression and mood disorders in multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 1991; 4: 62 – 77.
  31. Feinstein A. The neuropsychiatry of multiple sclerosis. Canadian Journal of Psychiatry 2004; 49: 157 – 163.
  32. Feinstein A. The clinical neuropsychiatry of multiple sclerosis. CNS Spectrums 2005; 10: 362.
  33. Gottschalk M, Kümpfel T, Flachenecker P, et al. Fatigue and regulation of the hypothalomo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 2005; 62: 277 – 280.
  34. Pollak Y, Orion E, Goshen I, Ovadia H, Yirmiya R. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Brain Behav Immun 2002; 16: 533 – 543.
  35. Penner IK, Bechtel N, Raselli C, et al. Fatigue in multiple sclerosis: Relation to depression, physical impairment, personality and action control. Mult Scler 2007; 13: 1161 – 1167.
  36. Colosimo C, Millefiorini E, Grasso MG, et al. Fatigue in MS is associated with specific clinical features. Acta Neurol Scand 1995; 92: 353 – 355.
  37. Schwartz CE, Coulthard-Morris L, Zeng Q. Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 1996; 77: 165 – 170.
  38. Lerdal A, Celius EG, Moum T. Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult Scler 2003; 9: 509 – 514.
  39. Penner IK, Raselli C, Stöcklin M, Opwis K, Kappos L, Calabrese P. The Fatigue Scale for Motor and Cognitive Functions (FSMC) – validation of a new instrument to assess multiple sclerosis-related fatigue Mult Scler 2009; 15: 1509 – 1517.
  40. Flachenecker P, Müller G, König H, Meissner H, Toyka K, Rieckmann P. Fatigue in multiple sclerosis. Development and validation of the "Würzburger Fatigue Inventory for MS". Nervenarzt 2006; 77: 165 – 174.
  41. Grossman P, Kappos L, Gensicke H, et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 2010; 75: 1141 – 1149.